Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nintx Logo
Nintx Growth Score
73
CB Rank
74417
Heat Score
42
Nintx develops a new generation of medicines leveraging biodiversity.
Founded
obfuscation
PrivateGrant São Paulo, Sao Paulo, Brazil1-10 nintx.com.br/en/index.php
Biopharma
Biotechnology
Chemical
Overview

Nintx
Total Funding
obfuscation
Growth Score
73
Heat Score
42

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score73
-4 pts
in past quarter
Heat Score 42
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nintx

CB Rank
74417
Nintx develops a new generation of medicines leveraging biodiversity.
Founded
obfuscation
PrivateGrant São Paulo, Sao Paulo, Brazil1-10 nintx.com.br/en/index.php
Biopharma
Biotechnology
Chemical

Funding Rounds

Grant
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Nintx Pesquisa e Desenvolvimento Ltda.
Also Known As Next Innovative Therapeutic
Operating Status Active
Company Type For Profit
About the Company
Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Contact Email miller.freitas@nintx.com.br
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

GAIA path®
A proprietary data analytics knowledge graph platform that maps and selects medicinal plants from biodiversity to modulate biological targets and the gut microbiome.
xGI biomics®
A proprietary platform that emulates the human gastrointestinal system and gut microbiome to study microbiome modulation after interventions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant
obfuscation
Grant - Nintx Logo
Grant - Nintx
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Guilherme Leal Logo
Guilherme Leal
—
Series A - Nintx Logo
Series A - Nintx
—
Guilherme Leal Logo
Guilherme Leal
—
Series A - Nintx Logo
Series A - Nintx
—
Guilherme Leal Logo
Guilherme Leal
—
Series A - Nintx Logo
Series A - Nintx
—
Guilherme Leal Logo
Guilherme Leal
—
Series A - Nintx Logo
Series A - Nintx
—
Guilherme Leal Logo
Guilherme Leal
—
Series A - Nintx Logo
Series A - Nintx
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 2
News

News and Press

News•Dec 16, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 16, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,378
575.49%
 in past month

Active Website Tech Count

19Nintx is actively using 19 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Apple Mobile Web Clips Icon.

Total IP

1Nintx has 1 registered patent in the 'Education; Cryptography; Display; Advertising; Seals' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Nintx's headquarters? Nintx is located in São Paulo, Sao Paulo, Brazil.Who invested in Nintx? Nintx has 8 investors including Guilherme Leal and  Pitanga Fund.When was the last funding round for Nintx? Nintx closed its last funding round on
obfuscation
from a Series A round.Who are Nintx's competitors? Alternatives and possible competitors to Nintx may include Phytolon, Kanvas Biosciences, and  The BioCollective.How much funding has Nintx raised to date? Nintx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|